歸創通橋-B(02190.HK)董事會主席趙中博士擬增持不超500萬港元股份
格隆匯11月26日丨歸創通橋-B(02190.HK)公佈,董事會獲趙中博士(董事會主席兼執行董事)吿知,在遵照適用法律法規的情況下,彼有意於本公吿日期起一週內自公開市場收購公司股份。根據趙博士,建議增持股份的代價總金額預計將不超過500萬港元。
此外,趙博士表示,擬收購的股份將持作中長期投資用途,且彼目前並無於收購後的12個月期間出售該等股份的意向。董事會認為,建議增持股份證明趙博士對公司的前景及增長潛力充滿信心。
於本公吿日期,趙博士及其一致行動人士持有9627萬股股份(佔公司股本總額約28.96%)及購股權,據此,將予發行最多129萬股股份(佔公司股本總額約0.39%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.